Shanghai Kaibao Equity Investment Management Co., Ltd. announced that it expects to receive CNY 60 million in funding from Shanghai Kaibao Pharmaceutical CO.,Ltd
Shanghai Kaibao Equity Investment Management Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 60 million on August 25, 2020. The transaction will include participation from returning investor Shanghai Kaibao Pharmaceutical CO.,Ltd (SZSE:300039). The transaction has been approved at the twelfth meeting of the fourth directorate and the tenth meeting of the fourth board of supervisors. As a result, the registered capital of the target company will increase to CNY 160 million.